Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients

被引:72
|
作者
Lang, Sonja [1 ]
Fairfied, Bradley [1 ]
Gao, Bei [1 ]
Duan, Yi [1 ,2 ]
Zhang, Xinlian [3 ]
Fouts, Derrick E. [4 ]
Schnabl, Bernd [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA
[3] Univ Calif San Diego, Div Biostat & Bioinformat, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[4] J Craig Venter Inst, Dept Genom Med, Rockville, MD USA
关键词
Microbiome; 16S sequencing; alcohol-related liver disease; metagenomics; GUT MICROBIOME; LIVER-DISEASE; PROFILE;
D O I
10.1080/19490976.2020.1785251
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Alcoholic hepatitis is the most severe form of alcohol-related liver disease. While the gut microbiome is known to play a role in disease development and progression, less is known about specific compositional changes of the gut bacterial microbiome associated with disease severity. Therefore, the aim of our study was to correlate gut microbiota features with disease severity in alcoholic hepatitis patients. Methods We used 16S rRNA gene sequencing on fecal samples from 74 alcoholic hepatitis patients, which were enrolled at 9 centers in Europe, the United States, and Mexico in a multi-center observational study. The relative abundance of gut bacterial taxa on genus level, as well as the microbiome diversity, was correlated to various clinical, laboratory, and histologic parameters. Results We observed a negative correlation between the model for end-stage liver disease score and Shannon diversity, independent of potentially confounding factors (P-adjust = 0.046). Alcoholic hepatitis patients with more severe disease had significantly decreased relative abundances ofAkkermansiawhile the relative abundance ofVeillonellawas increased. We observed a reduction in theBacteroidesabundance (P-adjust = 0.048) and Shannon diversity (P-adjust = 0.018) in antibiotic-treated patients and patients receiving steroids had an increase inVeillonellaabundance (P-adjust = 0.005), which was both independent of potentially confounding factors. Conclusion We observed distinct changes in the gut bacterial microbiome of alcoholic hepatitis patients with more severe disease. The gut bacterial microbiome might be an attractive target to prevent and treat this deadly disease.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Alcoholic Hepatitis and Disease Severity Are Associated With Distinct Shifts in Fecal Microbial Ecology
    Puri, Puneet
    Daita, Kalyani
    Mirshahi, Faridoddin
    Liangpunsakul, Suthat
    Chalasani, Naga P.
    Crabb, David W.
    Shah, Vijay
    Kamath, Patrick S.
    Gores, Gregory J.
    Katz, Barry P.
    Sikaroodi, Masoumeh
    Radaeva, Svetlana
    Gillevet, Patrick M.
    Sanyal, Arun J.
    HEPATOLOGY, 2016, 64 : 609A - 609A
  • [2] CHANGES IN GUT MICROBIOME IN PATIENTS WITH ALCOHOLIC HEPATITIS: HOW DISEASE SEVERITY CORRELATES WITH REDUCED MICROBIOTA DIVERSITY
    Fairfield, Bradley S.
    Lang, Sonja
    Gao, Bei
    Fouts, Derrick E.
    Schnabl, Bernd
    GASTROENTEROLOGY, 2020, 158 (06) : S1351 - S1351
  • [3] Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial
    Pande, Apurva
    Sharma, Shvetank
    Khillan, Vikas
    Rastogi, Archana
    Arora, Vinod
    Shasthry, Saggere Muralikrishna
    Vijayaraghavan, Rajan
    Jagdish, Rakesh
    Kumar, Manoj
    Kumar, Guresh
    Mondot, Stanislas
    Dore, Joel
    Sarin, Shiv K.
    HEPATOLOGY INTERNATIONAL, 2023, 17 (01) : 249 - 261
  • [4] Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial
    Apurva Pande
    Shvetank Sharma
    Vikas Khillan
    Archana Rastogi
    Vinod Arora
    Saggere Muralikrishna Shasthry
    Rajan Vijayaraghavan
    Rakesh Jagdish
    Manoj Kumar
    Guresh Kumar
    Stanislas Mondot
    Joél Dore
    Shiv K. Sarin
    Hepatology International, 2023, 17 : 249 - 261
  • [5] THROMBOELASTOGRAPHIC CHANGES IN ICU PATIENTS WITH ALCOHOLIC ASSOCIATED HEPATITIS
    Bajwa, Ramanpreet K.
    Kleb, Cerise
    Faisal, Muhammad Salman
    Khan, Muhammad Zarrar
    Khan, Afshin A.
    Lyu, Ruishen
    Angelini, Dana
    Esfeh, Jamak Modaresi
    GASTROENTEROLOGY, 2023, 164 (06) : S1281 - S1281
  • [6] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Fan Li
    Gang Sun
    Zikai Wang
    Wenming Wu
    He Guo
    Lihua Peng
    Lili Wu
    Xu Guo
    Yunsheng Yang
    Science China(Life Sciences), 2018, (07) : 770 - 778
  • [7] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Li, Fan
    Sun, Gang
    Wang, Zikai
    Wu, Wenming
    Guo, He
    Peng, Lihua
    Wu, Lili
    Guo, Xu
    Yang, Yunsheng
    SCIENCE CHINA-LIFE SCIENCES, 2018, 61 (07) : 770 - 778
  • [8] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Fan Li
    Gang Sun
    Zikai Wang
    Wenming Wu
    He Guo
    Lihua Peng
    Lili Wu
    Xu Guo
    Yunsheng Yang
    Science China Life Sciences, 2018, 61 : 770 - 778
  • [9] An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
    Nistal, Esther
    Saenz de Miera, Luis E.
    Ballesteros Pomar, Maria
    Sanchez-Campos, Sonia
    Victoria Garcia-Mediavilla, Maria
    Alvarez-Cuenllas, Begona
    Linares, Pedro
    Luis Olcoz, Jose
    Teresa Arias-Loste, Maria
    Maria Garcia-Lobo, Juan
    Crespo, Javier
    Gonzalez-Gallego, Javier
    Jorquera Plaza, Francisco
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (04) : 275 - 282
  • [10] Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity
    Smirnova, Ekaterina
    Puri, Puneet
    Muthiah, Mark D.
    Daitya, Kalyani
    Brown, Robert
    Chalasani, Naga
    Liangpunsakul, Suthat
    Shah, Vijay H.
    Gelow, Kayla
    Siddiqui, Mohammed S.
    Boyett, Sherry
    Mirshahi, Faridoddin
    Sikaroodi, Masoumeh
    Gillevet, Patrick
    Sanyal, Arun J.
    HEPATOLOGY, 2020, 72 (01) : 271 - 286